Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin

English version České info

Natural killer (NK) cells are an important element in the immune defense against the orthopox family members vaccinia virus (VV) and ectromelia virus (ECTV). NK cells are regulated through inhibitory and activating signaling receptors, the latter involving NKG2D and the natural cytotoxicity receptors (NCR), NKp46, NKp44 and NKp30. Here we report that VV infection results in an upregulation of ligand structures for NKp30 and NKp46 on infected cells, whereas the binding of NKp44 and NKG2D was not significantly affected. Likewise, infection with ectromelia virus (ECTV), the mousepox agent, enhanced binding of NKp30 and, to a lesser extent, NKp46. The hemagglutinin (HA) molecules from VV and ECTV, which are known virulence factors, were identified as novel ligands for NKp30 and NKp46. Using NK cells with selectively silenced NCR expression and NCR-CD3ζ reporter cells, we observed that HA present on the surface of VV-infected cells, or in the form of recombinant soluble protein, was able to block NKp30-triggered activation, whereas it stimulated the activation through NKp46. The net effect of this complex influence on NK cell activity resulted in a decreased NK lysis susceptibility of infected cells at late time points of VV infection when HA was expression was pronounced. We conclude that poxviral HA represents a conserved ligand of NCR, exerting a novel immune escape mechanism through its blocking effect on NKp30-mediated activation at a late stage of infection.

Vyšlo v časopise: Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin. PLoS Pathog 7(8): e32767. doi:10.1371/journal.ppat.1002195
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002195

Souhrn

Zdroje

1. MossB 2007 Poxviridae: The viruses and their replication. KnipeDMHowleyPM Fields Virology 2 Philadelphia: Lippincott Williams & Wilkins 2905 2946

2. FennerFHendersonDAAritaIJezekZLadnyiID 1988 Smallpox and its Eradication. Geneva World Health Organization

3. MossB 1996 Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci U S A 93 11341 11348

4. SmithGLSymonsJAKhannaAVanderplasschenAAlcamíA 1997 Vaccinia virus immune evasion. Immunol Rev 159 137 154

5. SeetBTJohnstonJBBrunettiCRBarrettJWEverettH 2003 Poxviruses and immune evasion. Annu Rev Immunol 21 377 423

6. KarupiahGCouparBRamshawIBoyleDBlandenR 1990 Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2. Immunol Cell Biology 68 325 333

7. KarupiahGBullerRMVan RooijenNDuarteCJChenJ 1996 Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol 70 8301 8309

8. SelinLKSantolucitoPAPintoAKSzomolanyi-TsudaEWelshRM 2001 Innate immunity to viruses: control of vaccinia virus infection by T cells. J Immunol 166 6784 6794

9. BelyakovIMEarlPDzutsevAKuznetsovVALemonM 2003 Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci U S A 100 9458 9463

10. XuRJohnsonAJLiggittDBevanMJ 2004 Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 172 6265 6271

11. BukowskiJFWodaBAHabuSOkumuraKWelshRM 1983 Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 131 1531 1537

12. BrutkiewiczRRKlausSJWelshRM 1992 Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression. Nat Immunol 11 203 214

13. JacobyROBhattPNBrownsteinDG 1989 Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol 108 49 58

14. ParkerAKParkerSYokoyamaWMCorbettJABullerRM 2007 Induction of natural killer cell responses by ectromelia virus controls infection. J Virol 81 4070 4079

15. HuangSHendriksWAlthageAHemmiSBluethmannH 1993 Immune response in mice that lack the interferon-gamma receptor. Science 259 1742 1745

16. DeonarainRAlcamíAAlexiouMDallmanMJGewertDR 2000 Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol 74 3404 3409

17. MartinezJHuangXYangY 2008 Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J Immunol 180 1592 1597

18. ChisholmSEReyburnHT 2006 Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J Virol 80 2225 2233

19. FangMLanierLLSigalLJ 2008 A role for NKG2D in NK cell-mediated resistance to poxviral disease. PLoS Pathog 4 e30

20. MorettaABottinoCVitaleMPendeDCantoniC 2001 Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19 197 223

21. LanierLL 2005 NK cell recognition. Annu Rev Immunol 23 225 274

22. MorettaLMorettaA 2004 Killer immunoglobulin-like receptors. Curr Opin Immunol 16 626 633

23. ArnonTIMarkelGMandelboimO 2006 Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 16 348 358

24. BloushtainNQimronUBar-IlanAHershkovitzOGazitR 2004 Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J Immunol 173 2392 2401

25. HershkovitzOJivovSBloushtainNZilkaALandauG 2007 Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry 46 7426 7436

26. HershkovitzOJarahianMZilkaABar-IlanALandauG 2008 Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immuno-receptors as an immunological tool. Glycobiology 18 28 41

27. Pogge von StrandmannESimhadriVRvon TresckowBSasseSReinersKS 2007 Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27 965 974

28. BrandtCSBaratinMYiECKennedyJGaoZFoxB 2009 The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 206 1495 1503

29. ByrdAHoffmannSCJarahianMMomburgFWatzlC 2007 Expression analysis of the ligands for the natural killer cell receptors NKp30 and NKp44. PLoS ONE 2 e1339

30. MandelboimOLiebermanNLevMPaulLArnonTI 2001 Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409 1055 1060

31. ArnonTILevMKatzGChernobrovYPorgadorA 2001 Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 31 2680 2689

32. GazitRGrudaRElboimMArnonTIKatzG 2006 Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7 517 523

33. JarahianMWatzlCFournierPArnoldADjandjiD 2009 Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. J Virol 83 8108 8121

34. ArnonTIAchdoutHLeviOMarkelGSalehN 2005 Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 6 515 523

35. ChisholmSEHowardKGomezMVReyburnHT 2007 Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors. J Infect Dis 195 1160 1168

36. VieillardVStromingerJLDebreP 2005 NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci USA 102 10981 10986

37. ZhangQYuYAWangEChenNDannerRL 2007 Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res 67 10038 10046

38. YuYAGalanisCWooYChenNZhangQ 2009 Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68. Mol Cancer Ther 8 141 151

39. ReadingPCSmithGL 2003 A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol 84 1973 1983

40. WorschechAChenNYuYAZhangQPosZ 2009 Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy. BMC Genomics 10 301 322

41. WorschechAHaddadDStroncekDFWangEMarincolaFM 2009 The immunologic aspects of poxvirus oncolytic therapy. Cancer Immunol Immunother 58 1355 1362

42. TurnerPCMoyerRW 2006 The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells. Virology 347 88 99

43. BrownCKTurnerPCMoyerRW 1991 Molecular characterization of the vaccinia virus hemagglutinin gene. J Virol 65 3598 3606

44. ArnonTIAchdoutHLiebermanNGazitRGonen-GrossT 2004 The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103 664 72

45. PessinoASivoriSBottinoCMalaspinaAMorelliL 1998 Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 188 953 960

46. PendeDParoliniSPessinoASivoriSAugugliaroR 1999 Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 190 1505 1516

47. Nolte-'t HoenENAlmeidaCRCohenNRNedvetzkiSYarwoodH 2007 Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication. Blood 109 670 673

48. AugugliaroRParoliniSCastriconiRMarcenaroECantoniC 2003 Selective cross-talk among natural cytotoxicity receptors in human natural killer cells. Eur J Immunol 33 1235 1241

49. StitzLBaenzigerJPircherHHengartnerHZinkernagelR 1986 Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J Immunol 36 4674 4680

50. BironCANguyenKBPienGCCousensLPSalazar-MatherTP 1999 Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 189 220

51. BarazLKhazanovECondiottiRKotlerMNaglerA 1999 Natural killer (NK) cells prevent virus production in cell culture. Bone Marrow Transplant 2 179 189

52. PaolettiE 1996 Applications of pox virus vectors to vaccination: an update. Proc Natl Acad Sci U S A 93 11349 11353

53. BiassoniRPessinoABottinoCPendeDMorettaL 1999 The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol 29 1014 1020

54. HollyoakeMCampbellRDAguadoB 2005 NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli. Mol Biol Evol 22 1661 1672

55. JinDYLiZLJinQHaoYWHouYD 1989 Vaccinia virus hemagglutinin. A novel member of the immunoglobulin superfamily. J Exp Med 170 2571 2576

56. PayneLG 1979 Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J Virol 31 147 155

57. KraussOHollinsheadRHollinsheadMSmithGL 2002 An investigation of the incorporation of cellular antigens in vaccinia virus particles. J Gen Virol 83 2347 2359

58. TurnerPCMoyerRW 2008 The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus. Virology 380 226 233

59. WagenaarTRMossB 2009 Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. J Virol 83 1546 1554

60. ShidaHHinumaYHatanakaMMoritaMKidokoroM 1988 Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene. J Virol 62 4474 4480

61. ZhangQLiangCYuYAChenNDandekarT 2009 The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation. Mol Genet Genomics 282 417 435

62. VanderplasschenAHollinsheadMSmithGL 1998 Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol 79 877 888

63. OmidvarNWangECBrennanPLonghiMPSmithRA 2006 Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity. J Immunol 176 2915 2923

64. HengelHEsslingerCPoolJGoulmyEKoszinowskiUH 1995 Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76 2987 2997

65. HoffmannSCSchellackCTextorSKonoldSSchmitzD 2007 Identification of CLEC12B, an inhibitory receptor on myeloid cells. J Biol Chem 2007. 282 22370 22375

66. BloethnerSHemminkiKThirumaranRKChenBMueller-BerghausJ 2006 Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes. Melanoma Res 16 297 307

67. PengSTrimbleCHeLTsaiYCLinCT 2006 Characterization of HLA-A2-restricted HPV-16 E7-specific CD8+ T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice. Gene Ther 13 67 77

68. TamYKMakiGMiyagawaBHennemannBTonnT 1999 Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum Gene Ther 10 1359 1373

69. JarahianMWatzlCIssaYAltevogtPMomburgF 2007 Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells. Int J Cancer 120 2625 2634

70. BrumLMTurnerPCDevickHBaqueroMTMoyerRW 2003 Plasma membrane localization and fusion inhibitory activity of the cowpox virus serpin SPI-3 require a functional signal sequence and the virus encoded hemagglutinin. Virology 306 289 302